In hepatocellular and lung adenocarcinoma, no association of the CTNNB1 mutational status with prognosis was found, while in certain subtypes of early stage endometrial carcinoma, CTNNB1 mutations predicted disease recurrence and reduced disease-free survival [111,112,113]. Here, CTNNB1 is linked to endometrial carcinoma.